ACG Clinical Guideline: Ulcerative Colitis in Adults

@article{Rubin2019ACGCG,
  title={ACG Clinical Guideline: Ulcerative Colitis in Adults},
  author={David T. Rubin and Ashwin N. Ananthakrishnan and Corey A Siegel and Bryan G. Sauer and Millie D. Long},
  journal={The American Journal of Gastroenterology},
  year={2019},
  volume={114},
  pages={384–413}
}
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) process. In instances where the evidence was not appropriate for GRADE, but there was consensus of… 
View on Wolters Kluwer
s3.gi.org
242 Citations
Highly Influential Citations
16
Background Citations
72
Methods Citations
11
Results Citations
3

Figures and Tables from this paper

242 Citations

Update of the PANCCO clinical practice guidelines for the treatment of ulcerative colitis in the adult population.
Modern surgery for ulcerative colitis
TLDR
A review of modern surgical practices in ulcerative colitis is presented, addressing some current controversies and diversities.
(Re)Appraising Remission in Ulcerative Colitis.
TLDR
The authors reexamine the definition of clinical remission and propose a novel approach to define remission in UC, which is based on the clinical context in which it is being used.
A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis.
TLDR
An approach to the treatment of high-risk UC in both the outpatient and inpatient settings is presented and a critical appraisal of alternative and emerging approaches to the management of patients with high- risk UC is presented.
The diagnosis and management of CMV colitis in IBD patients shows high practice variation: a national survey among gastroenterologists.
TLDR
It is shown that there is a high practice variation of diagnosis and management of CMV colitis in IBD amongst adult and pediatric gastroenterologists and the need for pragmatic clinical studies on different management strategies, in order to reduce practice variation and improve the quality of care.
Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis.
TLDR
The Korean guidelines for medical management of adult outpatients with moderate-to-severe UC and adult hospitalized patients with acute severe UC are presented, focusing on biologics and small molecules.
Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
TLDR
The epidemiology and disease course of UC across Asia is reviewed, including region-specific factors that may aid development of more cost-effective treatment approaches tailored to the needs of Asian populations.
Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician
TLDR
A review of biologic therapies for enteric diseases examines data on efficacy and safety, as well as considerations for using these therapies in clinical practice in inflammatory bowel diseases, enteric infections, and potentially in the increasingly prevalent disorder of eosinophilic esophagitis.
Therapeutic Class Overview Inflammatory Bowel Disease Agents
TLDR
The contents of the therapeutic class overviews on this website are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective.
TLDR
Tofacitinib is helpful in the treatment of patients where the standard conventional or biological therapies have failed or were not tolerated and with lower costs of the generic drug than the biologicals (or biosimilars), it could be an important therapy in low-middle-income countries.
...
...

References

SHOWING 1-10 OF 282 REFERENCES
Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines
TLDR
These guidelines provide clinically useful points to guide the management of UC in children and offer a standardized protocol that allows effective, timely management and monitoring of the disease course, while acknowledging that each patient is unique.
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
TLDR
Key issues that have emerged from discussions of the Montreal Working Party are highlighted and the relevance to clinical practice and research activities are highlighted.
Conventional Therapy of Ulcerative Colitis: Corticosteroids
TLDR
The judicious use of corticosteroids should be an integral part of care for all clinicians managing patients with ulcerative colitis and the evidence base for efficacy of various formulations is discussed.
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
TLDR
Evidence- and consensus-based recommendations for selecting the goals for treat-to-target strategies in patients with IBD are made available and future studies are needed to determine how these targets will change disease course and patients’ quality of life.
Surgery in ulcerative colitis: When? How?
Does rectal sparing ever occur in ulcerative colitis?
TLDR
There are several clinical situations in which the rectum may be partially, or completely, spared of active or chronic inflammation, and these are outlined below.
Biological Agents for Moderately to Severely Active Ulcerative Colitis
TLDR
A systematic review of randomized, controlled trials assessing biological agents as induction or maintenance therapy for moderately to severely active UC in adults to address this issue and compare the different treatment options.
The emerging role of histologic disease activity assessment in ulcerative colitis.
Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis.
TLDR
Endoscopic severity is associated with a worse outcome in ASC, and when the UCEIS is ≥7 on admission, almost all patients will need treatment with infliximab or ciclosporin beyond steroids.
Focally Enhanced Gastritis in Newly Diagnosed Pediatric Inflammatory Bowel Disease
TLDR
It is demonstrated that differences in FEG seen in pediatric CD and UC relate to not only their frequencies but also the morphology and relationship with other gastrointestinal lesions.
...
...